QHR@*VX>]'}.:DOK}^MZ)+[/GAE-_-2{U(
SYSTEM PROCESSING...
QHR@*VX>]'}.:DOK}^MZ)+[/GAE-_-2{U(
SYSTEM PROCESSING...
Posted: 2025-05-12 14:21:36 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-12 14:21:51 UTC
Verified By
Rollup News
A head-to-head study reveals that Eli Lilly's Zepbound leads to significantly more weight loss compared to Novo Nordisk's Wegovy.
Zepbound users experienced nearly 50% more weight loss than Wegovy users.
The study is the first head-to-head comparison of these two blockbuster obesity drugs.